Gustafsson, N., Stallknecht, S. E., Skovdal, M.
, Poulsen, P. B. & Østergaard, L. (2018).
Societal costs due to meningococcal disease: a national registry-based study.
ClinicoEconomics and Outcome Research,
10, 563-572.
https://doi.org/10.2147/CEOR.S175835Andersen, M. N., Hønge, B. L., Jespersen, S., Medina, C., Té, D. D. S.
, Laursen, A., Wejse, C., Erikstrup, C., Møller, H. J., Bissau HIV Cohort Study Group
& Østergaard, L. J. (2018).
Soluble Macrophage Mannose Receptor (sCD206/sMR) as a Biomarker in HIV-infection.
The Journal of Infectious Diseases,
218(8), 1291-1295.
https://doi.org/10.1093/infdis/jiy318
Hønge, B. L., Jespersen, S., Medina, C., Té, D. D. S., da Silva, Z. J.
, Christiansen, M., Kjerulff, B.
, Laursen, A. L., Wejse, C., Krarup, H.
, Erikstrup, C., Bissau HIV Cohort Study Group
& Østergaard, L. J. (2018).
The challenge of discriminating between HIV-1, HIV-2 and HIV-1/2 dual infections.
HIV Medicine,
19(6), 403-410.
https://doi.org/10.1111/hiv.12606
Rasmussen, T. A., McMahon, J. H., Chang, J. J., Audsley, J., Rhodes, A., Tennakoon, S., Dantanarayana, A., Spelman, T., Schmidt, T., Kent, S. J., Morcilla, V., Palmer, S., Elliott, J. H. & Lewin, S. R. (2018).
The effect of antiretroviral intensification with dolutegravir on residual virus replication in HIV-infected individuals: a randomised, placebo-controlled, double-blind trial.
The Lancet HIV,
5(5), e221-e230.
https://doi.org/10.1016/S2352-3018(18)30040-7
Shepherd, L.
, Borges, Á. H., Harvey, R., Bower, M., Grulich, A., Silverberg, M.
, Weber, J., Ristola, M., Viard, J.-P., Bogner, J. R., Gargalianos-Kakolyris, P., Mussini, C., Mansinho, K., Yust, I., Paduta, D., Jilich, D., Smiatacz, T., Radoi, R., Tomazic, J. ... EuroSIDA in EuroCOORD (2018).
The extent of B-cell activation and dysfunction preceding lymphoma development in HIV-positive people.
HIV Medicine,
19(2), 90-101.
https://doi.org/10.1111/hiv.12546Thomsen, D., Erikstrup, C., Jespersen, S., Medina, C., Té, D. D. S., Correira, F. G.
, Christiansen, M., Wejse, C., Krarup, H., Møller, B. K., Hønge, B. L. & Bissau HIV Cohort Study Group (2018).
The influence of HLA-types on disease progression among HIV-2 infected patients in Guinea-Bissau.
AIDS,
32(6), 721-728.
https://doi.org/10.1097/QAD.0000000000001758
Hallager, S., Lundh, A., Ladelund, S., Gerstoft, J.
, Laursen, A. L., Clausen, M. R., Balslev, U. & Weis, N. (2018).
The Prevalence of Human Immunodeficiency Virus Coinfection Among Patients Newly Diagnosed With Chronic Hepatitis B or C in Denmark: A Nationwide Cohort Study.
Open Forum Infectious Diseases,
5(12), ofy310.
https://doi.org/10.1093/ofid/ofy310Krarup, A. R., Abdel-Mohsen, M.
, Schleimann, M. H., Vibholm, L., Engen, P. A.
, Dige, A., Wittig, B.
, Schmidt, M., Green, S. J., Naqib, A., Keshavarzian, A., Deng, X.
, Olesen, R., Petersen, A. M., Benfield, T.
, Østergaard, L., Rasmussen, T. A., Agnholt, J., Nyengaard, J. R. ... Denton, P. W. (2018).
The TLR9 agonist MGN1703 triggers a potent type I interferon response in the sigmoid colon.
Mucosal Immunology,
11(2), 449–461.
https://doi.org/10.1038/mi.2017.59